These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4938270)

  • 1. Etiology of pyelonephritis: further evidence associating the production of experimental pyelonephritis with hemolysis in Escherichia coli.
    Fried FA; Vermeulen CW; Ginsburg MJ; Cone CM
    J Urol; 1971 Sep; 106(3):351-4. PubMed ID: 4938270
    [No Abstract]   [Full Text] [Related]  

  • 2. Etiology of pyelonephritis: significance of hemolytic Escherichia coli.
    Fried FA; Wong RJ
    J Urol; 1970 Jun; 103(6):718-21. PubMed ID: 4911063
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for obstructive etiology in intravenous bacterial pyelonephritis.
    Fry TL; Fried FA; Goven BA
    J Surg Res; 1975 Mar; 18(3):277-84. PubMed ID: 1094197
    [No Abstract]   [Full Text] [Related]  

  • 4. Etiology of pyelonephritis. Renal lysosome disruption by hemolytic Escherichia coli.
    de Pauw AP; Gill WB; Fried FA
    Invest Urol; 1971 Nov; 9(3):230-3. PubMed ID: 4944753
    [No Abstract]   [Full Text] [Related]  

  • 5. The isolation and characterization of an X-ray-sensitive ultraviolet-resistant mutant of Escherichia coli.
    Glickman BW; Zwenk H; van Sluis CA; Rörsch A
    Biochim Biophys Acta; 1971 Nov; 254(1):144-54. PubMed ID: 4943978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the route of infection in experimental coli pyelonephritis].
    Sack K; Freiesleben H; Wöhrmann W; Henkel W; Commichau R
    Virchows Arch A Pathol Pathol Anat; 1972; 355(4):323-32. PubMed ID: 4625543
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis.
    Prát V; Konícková L; Hatala M; Urbanová D
    Br J Exp Pathol; 1968 Feb; 49(1):60-7. PubMed ID: 4867859
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive treatment of experimental pyelonephritis with a combination of oxytetracycline and azathioprine.
    Hagemann I; Philipp H; Briedigkeit H; Dutz H
    Clin Nephrol; 1973; 1(6):372-6. PubMed ID: 4594998
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental pyelonephritis. Route of infection, course and immunological aspects.
    Tuan H; Hagemann I; Briedigkeit H; Dutz W
    Int Urol Nephrol; 1972; 4(3):285-95. PubMed ID: 4592133
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemolytic Escherichia coli in etiopathogenesis of pyelonephritis in rats--an experimental study.
    Akulwar SL; Kurhade AM; Saoji AM
    Indian J Pathol Microbiol; 1997 Jan; 40(1):47-9. PubMed ID: 9145611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet action spectra for mutation in Escherichia coli.
    Setlow JK; Boling ME
    Mutat Res; 1970 May; 9(5):437-42. PubMed ID: 4912783
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic and genetic characteristics of bleomycin-sensitive strain of Escherichia coli.
    Yamagami H; Ishizawa M; Endo H
    Gan; 1974 Feb; 65(1):61-7. PubMed ID: 4133035
    [No Abstract]   [Full Text] [Related]  

  • 13. Strain-dependent difference in susceptibility of mice to experimental ascending pyelonephritis.
    Guze PA; Kalmanson GM; Ishida K; Guze LB
    J Infect Dis; 1987 Sep; 156(3):523-5. PubMed ID: 3112242
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteremia in the pathogenesis of retrograde E. coli pyelonephritis in the rat.
    Fierer J; Talner L; Braude AI
    Am J Pathol; 1971 Aug; 64(2):443-56. PubMed ID: 4946881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli virulence and renal scarring.
    Topley N; Mackenzie RK; Steadman R; Williams JD
    J Infect Dis; 1989 Dec; 160(6):1081-3. PubMed ID: 2685127
    [No Abstract]   [Full Text] [Related]  

  • 16. [Induction of mutation].
    Takebe H
    Tanpakushitsu Kakusan Koso; 1972; 17():Suppl:12-24. PubMed ID: 4559520
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass screening for mutants with altered DNases by microassay techniques.
    Weiss B; Milcarek C
    Methods Enzymol; 1974; 29():180-93. PubMed ID: 4604728
    [No Abstract]   [Full Text] [Related]  

  • 18. A dominant constitutive phoR mutation in Escherichia coli.
    Pratt C; Gallant J
    Genetics; 1972 Oct; 72(2):217-26. PubMed ID: 4567286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental pyelonephritis: relationship with L-forms of Escherichia coli.
    Singh MG; Agarwal SC; Chugh KS; Chakravarty RN; Ganguly NK
    Indian J Med Res; 1972 Nov; 60(11):1579-83. PubMed ID: 4569912
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental pyelonephritis in the cat. 1. Gross and histological changes.
    Kelly DF; Lucke VM; McCullagh KG
    J Comp Pathol; 1979 Jan; 89(1):125-39. PubMed ID: 370162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.